GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 171 (2-3) , 211-222
- https://doi.org/10.1016/0009-8981(88)90146-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylationClinical Pharmacology & Therapeutics, 1985
- Plasma concentrations of nortriptyline and its 10‐hydroxy metabolite in depressed patients‐relationship to the debrisoquine hydroxylation metabolic ratio.British Journal of Clinical Pharmacology, 1985
- INVITRO INHIBITION STUDIES OF 2 ISOZYMES OF HUMAN-LIVER CYTOCHROME-P-450 - MEPHENYTOIN PARA-HYDROXYLASE AND SPARTEINE MONOOXYGENASE1985
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984
- DEXTROMETHORPHANAS A SAFE PROBE FOR DEBRISOQUINE HYDROXYLATION POLYMORPHISMThe Lancet, 1984
- Sparteine oxidation by the human liver: Absence of inhibition by mephenytoinClinical Pharmacology & Therapeutics, 1984
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas—liquid chromatography and high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982